Association of Midlife to Late-Life Blood Pressure Patterns With Incident Dementia.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
13 08 2019
Historique:
entrez: 14 8 2019
pubmed: 14 8 2019
medline: 31 8 2019
Statut: ppublish

Résumé

The association between late-life blood pressure (BP) and cognition may depend on the presence and chronicity of past hypertension. Late-life declines in blood pressure following prolonged hypertension may be associated with poor cognitive outcomes. To examine the association of midlife to late-life BP patterns with subsequent dementia, mild cognitive impairment, and cognitive decline. The Atherosclerosis Risk in Communities prospective population-based cohort study enrolled 4761 participants during midlife (visit 1, 1987-1989) and followed-up over 6 visits through 2016-2017 (visit 6). BP was examined over 24 years at 5 in-person visits between visits 1 and 5 (2011-2013). During visits 5 and 6, participants underwent detailed neurocognitive evaluation. The setting was 4 US communities: Washington County, Maryland; Forsyth County, North Carolina; Jackson, Mississippi; and Minneapolis, Minnesota. Follow-up ended on December 31, 2017. Five groups based on longitudinal patterns of normotension, hypertension (>140/90 mm Hg), and hypotension (<90/60 mm Hg) at visits 1 to 5. Primary outcome was dementia onset after visit 5, based on Ascertain Dementia-8 informant questionnaires, Six-Item Screener telephone assessments, hospital discharge and death certificate codes, and the visit 6 neurocognitive evaluation. Secondary outcome was mild cognitive impairment at visit 6, based on the neurocognitive evaluation. Among 4761 participants (2821 [59%] women; 979 [21%] black race; visit 5 mean [SD] age, 75 [5] years; visit 1 mean age range, 44-66 years; visit 5 mean age range, 66-90 years), there were 516 (11%) incident dementia cases between visits 5 and 6. The dementia incidence rate for participants with normotension in midlife (n = 833) and late life was 1.31 (95% CI, 1.00-1.72 per 100 person-years); for midlife normotension and late-life hypertension (n = 1559), 1.99 (95% CI, 1.69-2.32 per 100 person-years); for midlife and late-life hypertension (n = 1030), 2.83 (95% CI, 2.40-3.35 per 100 person-years); for midlife normotension and late-life hypotension (n = 927), 2.07 (95% CI, 1.68-2.54 per 100 person-years); and for midlife hypertension and late-life hypotension (n = 389), 4.26 (95% CI, 3.40-5.32 per 100 person-years). Participants in the midlife and late-life hypertension group (hazard ratio [HR], 1.49 [95% CI, 1.06-2.08]) and in the midlife hypertension and late-life hypotension group (HR, 1.62 [95% CI, 1.11-2.37]) had significantly increased risk of subsequent dementia compared with those who remained normotensive. Irrespective of late-life BP, sustained hypertension in midlife was associated with dementia risk (HR, 1.41 [95% CI, 1.17-1.71]). Compared with those who were normotensive in midlife and late life, only participants with midlife hypertension and late-life hypotension had higher risk of mild cognitive impairment (37 affected individuals (odds ratio, 1.65 [95% CI, 1.01-2.69]). There was no significant association of BP patterns with late-life cognitive change. In this community-based cohort with long-term follow-up, sustained hypertension in midlife to late life and a pattern of midlife hypertension and late-life hypotension, compared with midlife and late-life normal BP, were associated with increased risk for subsequent dementia.

Identifiants

pubmed: 31408138
pii: 2747672
doi: 10.1001/jama.2019.10575
pmc: PMC6692677
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

535-545

Subventions

Organisme : NHLBI NIH HHS
ID : U01 HL096812
Pays : United States
Organisme : NIA NIH HHS
ID : K01 AG050699
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL096902
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL070825
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL096899
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL096814
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL096917
Pays : United States
Organisme : NIA NIH HHS
ID : K24 AG052573
Pays : United States
Organisme : NIA NIH HHS
ID : T32 AG027668
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Am J Geriatr Cardiol. 2002 Jan-Feb;11(1):30-3
pubmed: 11773713
Arch Neurol. 2003 Aug;60(8):1123-8
pubmed: 12925370
Stroke. 2004 Aug;35(8):1810-5
pubmed: 15232128
Neurology. 2006 Dec 12;67(11):1942-8
pubmed: 17159098
Psychol Aging. 2006 Dec;21(4):774-89
pubmed: 17201497
Neurobiol Aging. 2009 Feb;30(2):222-8
pubmed: 17673335
Arch Neurol. 2007 Dec;64(12):1734-40
pubmed: 18071036
Am J Pathol. 2010 Jul;177(1):300-10
pubmed: 20472896
Ann Emerg Med. 2011 Jun;57(6):653-61
pubmed: 20855129
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Epidemiology. 2011 Sep;22(5):646-59
pubmed: 21705906
Arch Surg. 2011 Jul;146(7):865-9
pubmed: 21768435
Age Ageing. 2011 Nov;40(6):684-9
pubmed: 21890481
Nat Rev Neurosci. 2011 Nov 03;12(12):723-38
pubmed: 22048062
Ann Neurol. 2012 Jun;71(6):825-33
pubmed: 22447734
Int J Geriatr Psychiatry. 2013 Oct;28(10):1045-53
pubmed: 23335009
Neurobiol Aging. 2014 Jan;35(1):64-71
pubmed: 23969178
Epidemiology. 2013 Nov;24(6):886-93
pubmed: 24030502
Kidney Blood Press Res. 2013;38(2-3):205-16
pubmed: 24732208
Alzheimer Dis Assoc Disord. 2015 Jan-Mar;29(1):32-44
pubmed: 24759546
Neurology. 2014 Jun 17;82(24):2187-95
pubmed: 24898928
JAMA Neurol. 2014 Oct;71(10):1218-27
pubmed: 25090106
Epidemiology. 2015 Nov;26(6):878-87
pubmed: 26414855
Am J Epidemiol. 1989 Apr;129(4):687-702
pubmed: 2646917
N Engl J Med. 2015 Nov 26;373(22):2103-16
pubmed: 26551272
Alzheimers Dement (Amst). 2016;2:1-11
pubmed: 26949733
Alzheimers Dement. 2016 Aug;12(8):890-9
pubmed: 27139841
Curr Hypertens Rep. 2017 Mar;19(3):24
pubmed: 28299725
JAMA. 2017 Apr 11;317(14):1443-1450
pubmed: 28399252
JAMA Neurol. 2017 Oct 1;74(10):1246-1254
pubmed: 28783817
Hypertension. 2019 Jan;73(1):197-205
pubmed: 30571554
Clin Chem. 1983 Jun;29(6):1075-80
pubmed: 6851096
Clin Chem. 1982 Jun;28(6):1379-88
pubmed: 7074948
Lancet. 1996 Apr 27;347(9009):1141-5
pubmed: 8609748
Stroke. 1998 Nov;29(11):2334-40
pubmed: 9804644

Auteurs

Keenan A Walker (KA)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

A Richey Sharrett (AR)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Aozhou Wu (A)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Andrea L C Schneider (ALC)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Marilyn Albert (M)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Pamela L Lutsey (PL)

School of Public Health, Division of Epidemiology and Community Health, University of Minnesota, Minneapolis.

Karen Bandeen-Roche (K)

Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Josef Coresh (J)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Alden L Gross (AL)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Johns Hopkins Center on Aging and Health, Baltimore, Maryland.

B Gwen Windham (BG)

Division of Geriatrics, Department of Medicine, University of Mississippi Medical Center, Jackson.

David S Knopman (DS)

Department of Neurology, Mayo Clinic, Rochester, Minnesota.

Melinda C Power (MC)

Department of Epidemiology and Biostatistics, George Washington University Milken Institute School of Public Health, Washington, DC.

Andreea M Rawlings (AM)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Thomas H Mosley (TH)

Division of Geriatrics, Department of Medicine, University of Mississippi Medical Center, Jackson.

Rebecca F Gottesman (RF)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH